Adverum Biotechnologies News

Adverum Biotechnologies | S-3: Registration statement for specified transactions by certain issuers

Mar 21 17:27 ET

Adverum Biotechnologies | 8-K: Current report

Mar 20 16:19 ET

Adverum Biotechnologies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 18 17:01 ET

Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates

Mar 18 16:12 ET

Adverum Biotechnologies | S-3: Registration statement for specified transactions by certain issuers

Mar 4 16:41 ET

Adverum Biotechnologies | 8-K: Current report

Feb 8 08:50 ET

Adverum Biotechnologies | 8-K: Current report

Feb 6 16:48 ET

Adverum Biotechnologies | 8-K: Current report

Feb 5 17:10 ET

Adverum Biotechnologies | 8-K: Current report

Dec 8, 2023 16:11 ET

Adverum Biotechnologies | 8-K/A: Current report (Amendment)

Dec 4, 2023 16:09 ET

Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights

Nov 9, 2023 16:07 ET

Adverum Biotechnologies | 8-K: Current report

Nov 6, 2023 16:10 ET

Adverum Biotechnologies | 8-K: Adverum Biotechnologies Completes Enrollment of Phase 2 LUNA Trial in Wet AMD and Reports Second Quarter 2023 Financial Results

Aug 10, 2023 16:09 ET

Adverum Biotechnologies | 8-K: Current report

Aug 4, 2023 16:18 ET

Adverum Biotechnologies | 8-K: Current report

Jun 14, 2023 16:01 ET

Adverum Biotechnologies | 8-K: Current report

Jun 9, 2023 16:29 ET

Adverum Biotechnologies | 8-K: Current report

May 25, 2023 06:29 ET

Adverum Biotechnologies | 8-K: Current report

May 19, 2023 16:07 ET

Adverum Biotechnologies | 8-K: Current report

May 11, 2023 16:45 ET

Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports First Quarter 2023 Financial Results

May 11, 2023 16:10 ET